Drug intelligence / Profile preview

sodium hyaluronate (HAN Biomedical)

Development stage
Unknown
Lead developer
HAN Biomedical
Modality
Implantable Hydrogels → Hydrogel Systems → Drug Delivery Systems, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems
Administration
Topical, Vaginal
01

Overview

Sodium hyaluronate (HAN Biomedical) is a high molecular weight (HMW), natural hyaluronic acid formulated as a vaginal moisturizing gel. Developed by HAN Biomedical Inc., it is primarily indicated for the treatment of genitourinary syndrome of menopause (GSM), as well as vaginal dryness resulting from other conditions such as ovarian or breast cancer treatments. As a non-hormonal therapy, it functions by binding to water molecules to provide long-lasting hydration to the vaginal mucosa and forming a protective physical barrier that supports tissue integrity. This mechanism helps alleviate common symptoms of vaginal atrophy, including dryness, itching, and dyspareunia. The product is designed to promote epithelial repair and restore the physiological environment of the vaginal wall through its high water-retention capacity and potential interaction with cellular receptors like CD44.

Brand names
Hymois Vaginal Gel
Other names
High molecular weight hyaluronic acid vaginal gelHMW HA vaginal gelVaginal Moisturizing Gel
02

Targets

CD44 (CD44 antigen)

Beyond the preview

Go deeper on sodium hyaluronate (HAN Biomedical).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on sodium hyaluronate (HAN Biomedical).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call